Evidence map›Paper›PMID 32479682›Full record

Observational studyBJOG : an international journal of obstetrics and gynaecology2020

Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study.

M Mendoza, I Garcia-Ruiz, N Maiz, C Rodo, P Garcia-Manau, B Serrano, R M Lopez-Martinez, J Balcells, N Fernandez-Hidalgo, E Carreras and 1 more

2 registry-linked trialsAbstract readObservational Study
In one paragraph

Observational study in BJOG : an international journal of obstetrics and gynaecology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 195 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
195citing papers in PubMed, 13 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04443140 completednot on this map

Evaluation of COVID-19 Incidence in Patients With Preeclampsia During Pandemic

Typeobservational_patient_registrySponsorZeynep Kamil Maternity and Pediatric Research and Training HospitalRan2020 to 2020Enrolled131ConditionsCovid-19, Preeclampsia, Pregnancy RelatedArmsPCR, lung ultrasound
NCT04779749 completednot on this map

Pregnancy Outcomes According to the Gestational Age of Acquiring COVID-19 : an International Case-control Study

TypeobservationalSponsorBrugmann University HospitalRan2020 to 2021Enrolled10,925ConditionsCovid19ArmsData extraction from medical files
3 · Its place in the literature

Who cites it

195 citing papers in PubMed, 13 syntheses or guidelines pooled it.

  1. COVID-19 and Preeclampsia: A Systematic Review of Pathophysiological Interactions.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2021
    Pooled it
  6. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2021
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Guideline
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

135 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

M MendozaMaternal-Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-3030-3833
I Garcia-RuizMaternal-Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-0717-7795
N MaizMaternal-Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0001-8261-6383
C RodoMaternal-Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0001-8801-5677
P Garcia-ManauMaternal-Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-2415-1626
B SerranoMaternal-Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
R M Lopez-MartinezBiochemistry Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
J BalcellsPaediatric Critical Care Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-8341-6508
N Fernandez-HidalgoDepartment of Infectous Diseases, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-2115-344X
E CarrerasMaternal-Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0003-3471-7248
A SuyMaternal-Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.ORCID 0000-0003-2987-6105

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the incidence of clinical, ultrasonographic and biochemical findings related to pre-eclampsia (PE) in pregnancies with COVID-19, and to assess their accuracy to differentiate between PE and the PE-like features associated with COVID-19.

designA prospective, observational study.

settingTertiary referral hospital.

participantsSingleton pregnancies with COVID-19 at >20

methodsForty-two consecutive pregnancies were recruited and classified into two groups: severe and non-severe COVID-19, according to the occurrence of severe pneumonia. Uterine artery pulsatility index (UtAPI) and angiogenic factors (soluble fms-like tyrosine kinase-1/placental growth factor [sFlt-1/PlGF]) were assessed in women with suspected PE.

main outcome measuresIncidence of signs and symptoms related to PE, such as hypertension, proteinuria, thrombocytopenia, elevated liver enzymes, abnormal UtAPI and increased sFlt-1/PlGF.

resultsThirty-four cases were classified as non-severe and 8 as severe COVID-19. Five (11.9%) women presented signs and symptoms of PE, all five being among the severe COVID-19 cases (62.5%). However, abnormal sFlt-1/PlGF and UtAPI could only be demonstrated in one case. One case remained pregnant after recovery from severe pneumonia and had a spontaneous resolution of the PE-like syndrome.

conclusionsPregnant women with severe COVID-19 can develop a PE-like syndrome that might be distinguished from actual PE by sFlt-1/PlGF, LDH and UtAPI assessment. Healthcare providers should be aware of its existence and monitor pregnancies with suspected pre-eclampsia with caution. TWEETABLE ABSTRACT: This study shows that a pre-eclampsia-like syndrome could be present in some pregnancies with severe COVID-19.

Indexed as

AdultAlanine TransaminaseAspartate AminotransferasesBetacoronavirusBlood PressureCoronavirus InfectionsCOVID-19FemaleHELLP SyndromeHumansL-Lactate DehydrogenasePandemicsPlacenta Growth FactorPneumonia, ViralPre-EclampsiaPregnancyAlanine TransaminaseAspartate AminotransferasesFLT1 protein, humanL-Lactate DehydrogenasePGF protein, humanPlacenta Growth FactorVascular Endothelial Growth Factor Receptor-1Angiogenic factorsCOVID-19PlGFpre-eclampsiapre-eclampsia-like syndromepregnancySARSSARS-CoV-2sFlt-1

Identifiers

PMID32479682
PMCPMC7300912

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.